Latest Breaking News On - Jean louis dasseux - Page 1 : comparemela.com

ABIONYX Pharma Completes a Capital Increase in Favor of Categories of Persons

ABIONYX Pharma Completes a Capital Increase in Favor of Categories of Persons
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Arthur rouillCyrille tupinEmmanuel huynhNicolas fossiezJean louis dasseuxSadok belmokhtarLouis victor delouvrierLuc demarreChief executive officerAnnual general meetingGeneral regulationsDes marchRegistration documentVictor delouvrier

ABIONYX Pharma Accelerates Its Development by Launching a New Biomanufacturing Campaign Based on the Recently Announced Robust Innovative Process Supported by an Equity-linked Financing Facility

ABIONYX Pharma Accelerates Its Development by Launching a New Biomanufacturing Campaign Based on the Recently Announced Robust Innovative Process Supported by an Equity-linked Financing Facility
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Pays de la loireCyrille tupinEmmanuel huynhLouis victor delouvrierLuc demarreArthur rouillNicolas fossiezSadok belmokhtarJean louis dasseuxIris pharma holdingDes marchBonds redeemableNew sharesChief executive officerAnnual general meetingRegistration document

ABIONYX Pharma Announces the Completion of a Contribution in Kind to the Company of 100% of the Capital of IRIS Pharma Holding, Fully Compensated by the Issue of New Shares at a Price of €3 60 Per Share to Become a Specialist of Bioproducts

IRIS Pharma becomes a subsidiary of ABIONYX Pharma and remains independent in its service activities for major pharmaceutical and biotech companies in the ophthalmology sector A potential

United statesJean louis dasseuxLuc demarreYann quentricPierre paul elenaArthur rouillIris pharmaCyrille tupinChristian chavyLouis victor delouvrierM emmanuel huynhSadok belmokhtarPharma holdingIris pharma holdingFully compensatedNew shares

ABIONYX Pharma: ABIONYX Announces the Success of Its Capital Increase in Cash by Private Placement at a Price of €3 60 Per Share

Regulatory News: ABIONYX Pharma (Paris:ABNX) (FR0012616852 ABNX PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients

United statesJean louis dasseuxLuc demarreEmmanuel huynhArthur rouillIris pharmaCyrille tupinChristian chavyLouis victor delouvrierPharma holdingRegulatory newsChief executive officerFrench monetaryFinancial codeGeneral meetingRegistration document

ABIONYX Announces the Success of Its Capital Increase in Cash by Private Placement at a Price of €3 60 Per Share - Press Release

Regulatory News: ABIONYX Pharma (PARIS:ABNX) (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and

United statesIris pharmaCyrille tupinJean louis dasseuxChristian chavyLuc demarreEmmanuel huynhPharma holdingRegulatory newsChief executive officerFrench monetaryFinancial codeGeneral meetingRegistration documentNorth america